Mediastinal Staging in Non-Small Cell Lung Cancer

Ziv Gamliel

doi:10.1016/j.soc.2016.02.004

Mediastinal Staging in Non-Small Cell Lung Cancer

Surg Oncol Clin N Am. 2016 Jul;25(3):493-502. doi: 10.1016/j.soc.2016.02.004.

Author

Ziv Gamliel¹

Affiliation

¹ Thoracic Surgery, Angelos Center for Lung Diseases, MedStar Franklin Square Medical Center, MedStar Harbor Hospital, 9103 Franklin Square Drive, Suite 1800, Baltimore, MD 21237, USA. Electronic address: ziv.gamliel@medstar.net.

PMID: 27261911
DOI: 10.1016/j.soc.2016.02.004

Abstract

In the absence of distant metastases, lung cancer treatment is determined by the results of mediastinal lymph node staging. Occult mediastinal lymph node metastases can be missed by radiologic and needle-based staging methods. Aggressive staging of mediastinal lymph nodes improves staging accuracy. Improved accuracy of mediastinal lymph node staging results in more appropriate lung cancer treatment. Improved accuracy of mediastinal lymph node staging can improve stage-specific survival from lung cancer.

Keywords: Endobronchial ultrasound; Lung cancer staging; Mediastinal lymph nodes; Mediastinoscopy.

Publication types

Review

MeSH terms

Carcinoma, Non-Small-Cell Lung / pathology*
Carcinoma, Non-Small-Cell Lung / secondary*
Humans
Lung Neoplasms / diagnosis
Lung Neoplasms / pathology*
Lymphatic Metastasis / pathology*
Mediastinal Neoplasms
Mediastinum / pathology
Neoplasm Staging / methods*